RecruitingNot Applicable

Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Norway50 participantsStarted 2022-10-01

Plain-language summary

Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subfoveal presence of SRF on OCT
✓. Present attack is 1st -3rd attack of CSC
✓. Subfoveal presence of SRF on OCT
✓. Subjective visual loss/symptoms
✓. Characteristic appearance of chronic CSC on FAF, fluorescein angiography (FA), and indocyanin angiography (ICGA) and OCT
✓. Patient history and examination consistent with chronic CSC

What they're measuring

Change in mean blur rate

Timeframe: 6 months

Change in pulse wave form analysis

Timeframe: 6 months

Trial details

NCT IDNCT05589974

SponsorHelse Stavanger HF

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-12-31

Contact for this trial

Vegard Forsaa, MD PhD

+4748152212 forsaa@gmail.com

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials